Submit manuscript...
eISSN: 2377-4304

Obstetrics & Gynecology International Journal

Research Article Volume 17 Issue 6

Multicenter study on the prevalence of human papillomavirus infection, genotype distribution, and cytological findings in public hospitals in the city of buenos Aires

Correa Lucena M, Leroux F, Clarizza L, Sappia J, Zamora F, Rotenberg A, Santamaria C, Vaccaro S, Bensadon C, Galland ME, Kugler M, Bersi F, Dejo Ylma C, Cvitanich F, Saczuk S, Marchetta F, Carrasco Maldonado M, Tejo M, Gomez MN, Ariel L, Shayo S, Dilernia N, Romero C, Gomez Decort J, López Della Vecchia D, Zurita D, Santome Osuna A, Pizarro G

Received: November 05, 2026 | Published: November 16, 2026

Citation: Lucena CM, Leroux F, Clarizza L, et al. Multicenter study on the prevalence of human papillomavirus infection, genotype distribution, and cytological findings in public hospitals in the city of buenos Aires. Obstet Gynecol Int J. 2026;17(5):249-253. DOI: 10.15406/ogij.2026.17.00854

Download PDF

Abstract

Introduction: Cervical cancer (CC) is a public health problem of global significance, with persistent human papillomavirus (HPV) infection being its primary etiological factor. People living with HIV constitute a high-risk population.
Objective: To characterize the prevalence and genotypic distribution of HPV and its association with high-grade cytology (HG) findings in women treated at public hospitals in Buenos Aires, while exploratorily assessing the impact of HIV serostatus on these parameters.
Materials and methods: A descriptive, retrospective, multicenter, cross-sectional study conducted at four public hospitals in the GCABA (Fernández, Argerich, Durand, and Penna). Study period: March 2022–December 2025. Patients aged ≥30 years who were not pregnant and screened with the Abbott HPV test were included. Patients with a history of conization, hysterectomy, lack of follow-up, or incomplete data were excluded. Genotype categories were defined as mutually exclusive, with “single infection” defined as the presence of a single high-risk genotype and “multiple” defined as coinfection with two or more. For the exploratory analysis by serological status, two groups were formed: confirmed HIV-positive patients and HIV-negative patients or those with no serology record (reference group).
Results: Of the 8,444 patients screened, 7,888 were included. The overall prevalence of HPV was 15.8% (n=1,246). In the HPV-positive population, the “other” category predominated as a single infection (72%, n=892), followed by genotype 16 alone (16%, n=205), genotype 18 alone (4%, n=54), and multiple infections (8%, n=95). The prevalence of HG results in the HPV-positive population was 17% (n=209). HIV-positive patients had a higher prevalence of HPV than the rest of the population (28.3% vs. 14.7%; p<0.00001) and a higher frequency of multiple infections (13% vs. 7%; p=0.002), with no significant differences in HG results (21% vs. 16%; p=0.09). Among HIV-positive patients with HG (n=38), a CD4 count <200 cells/mm³ (p<0.001), detectable viral load (p<0.001), and lack of antiretroviral therapy (ART) (p=0.01) were associated with a higher frequency of HG lesions.
Conclusion: The findings confirm the predominance of high-risk genotypes other than 16/18, reinforcing the importance of extended genotyping over strategies based solely on HPV 16/18 for risk stratification. The higher prevalence of HPV and multiple co-infections in HIV-positive individuals supports the need for differentiated screening algorithms. Immunosuppression without ART was associated with a higher risk of HG lesions in this subgroup

Keywords: human papillomavirus, human immunodeficiency virus, cervical cancer, women, cytologic lesions, genotypes

Creative Commons Attribution License

©2026 Lucena, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.